NCT06291649 is a clinical trial in Acute Intoxication, sponsored by Meyer Children's Hospital IRCCS.

Who is sponsoring NCT06291649?

NCT06291649 is sponsored by Meyer Children's Hospital IRCCS.

What condition does NCT06291649 study?

NCT06291649 studies Acute Intoxication.

Is NCT06291649 still recruiting?

NCT06291649 is currently recruiting now. Last updated 4 March 2024.

Last reviewed 2024-03-04 · How we verify

NCT06291649

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multicentre Prospective Observational Study of Acute Intoxications in Paediatric Age

Recruiting now Last updated 4 March 2024

What this trial tests

trial in Acute Intoxication in 90 participants. Currently enrolling.

Timeline

5 April 2023

Primary endpoint
5 April 2033

5 August 2033

Quick facts

Lead sponsor	Meyer Children's Hospital IRCCS
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	90
Start date	5 April 2023
Primary completion	5 April 2033
Estimated completion	5 August 2033
Sites	31 locations across Italy

Conditions studied

Acute Intoxication — all drugs for Acute Intoxication →

Sponsor

Meyer Children's Hospital IRCCS

Who can join

Adults 1 Month to 16, any sex, with Acute Intoxication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute intoxications represent a major public health problem, especially when affect a population such as children, who are vulnerable and at greater risk of unintentional and preventable poisonings. The primary objective of the study is to assess the epidemiology of acute intoxications in paediatric age with respect to the social and care factors associated with it in order to then implement in the future a better diagnostic-therapeutic management modality on a national level. Thi is a prospective non-profit multicentre observational cohort study on acute intoxications in the paediatric age, conducted by AMIETOX, aimed at CAVs (Poison Control Centres) and PSPs (Paediatric emergency room).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Meyer Children's Hospital IRCCS trials

Trials by the same sponsor.

NCT07412782 — REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) · NA · recruiting
NCT07363304 — Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People Wi · recruiting
NCT07412769 — ASMact: Study on Management of Bronchial Asthma · recruiting
NCT07468461 — CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome · recruiting
NCT07348263 — EFESO: Study on Juvenile Onset Eosinophilic Fasciitis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06291649 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Meyer Children's Hospital IRCCS
Last refreshed: 4 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06291649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing